Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Carditis

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Carditis in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, H1
Kunitsugu, I1
Fukuda, K1
Matsuzaki, M1
Sano, M1
Takahashi, T1
Zhu, SJ1
Sumino, H1
Saegusa, S1
Nakahashi, T1
Iwai, K1
Morimoto, S1
Kanda, T1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Carditis

ArticleYear
Diverse stage-dependent effects of glucocorticoids in a murine model of viral myocarditis.
    Journal of cardiology, 2013, Volume: 61, Issue:3

    Topics: Acute Disease; Animals; Coxsackievirus Infections; Cyclooxygenase Inhibitors; Dexamethasone; Disease

2013
Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
    Life sciences, 2005, Nov-26, Volume: 78, Issue:2

    Topics: Adiponectin; Animals; Body Weight; Cardiovirus Infections; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi

2005